5 miljarder till superkluster

Världens mest attraktiva plats för life science. Det är målet för femmiljardersprojektet , en ny stadsdel som byggs för att förena Stockholm och Solna. År 2025 kommer ytan att husera 600 000 kvadratmeter kontor och laboratorier tillägnade life science, inklusive ett helt nytt universitetssjukhus.

Sverige patenterar och Danmark gör business

Sverige har det största antalet patent och vetenskapliga publikationer i Skandinavien, medan danskarna är bättre på att skapa en bra pipeline från sin grundforskning. - Danmark är mer framgångsrikt på att ta innovationer hela vägen, säger Jacob Ehnfors, Swedenbio.

Så ska Svensson älska pharma

Oväntad funktion för programmerad celldöd

En receptor som motverkar att immunförsvaret attackerar friska celler har ingen eller motsatt effekt hos apoptotiska celler. Forskningen kan komma att få betydelse för behandling av cancer och autoimmuna sjukdomar.

Hallå där Per Janson...

...analytiker på Vetenskapsådet som har studerat hur forskningspengar inom medicin fördelas mellan män och kvinnor. Vad har du kommit fram till?

Finmekanik fri från fingeravtryck

Den batteridrivna automatpipetten Pipetboy Vacuum tweezers från Integra har fått ett nytt tillbehör i form av en minimal vakuumpropp.

Hey there Summer Eriksson......

.....biomedical analysist at Akademsika sjukhuset in Uppsala. Why are you here at Biotech Forum and Scanlab?

Partnering offer for scientists and medics

For the first time in the history of Biotech Forum, scientists and medics are invited to join the partnering event. I

Relax at the After Fair

Round off the first day of the fair by visiting the After Fair. You can reload with entertainment from talented artists such as Patrik Isaksson, The Gentlemen and Ellinor Asp and take the opportunity to mingle with old and new aquaintances.

Clinical trials in large scale to Stockholm

Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per study, so that companies do not have to go abroad for clinical trials.

Definite answer with new cancerous gene

A newly discovered cancer gene is enabling the diagnosis of adenoid cystic caranoima using a genetic test.

Cell incubator with built-in microscope

InCu-view live is an incubator from Sanyo for cell or embryo culture with documentation functionality.

Discovery of new role for leukemia gene

Martin Bergö and his colleagues have studied two gene variants that often occur in acute leukemias. One gene codes for the protein RAS, which accelerates cell division in several cancers.

Mingling do's and don'ts

Linkedin, Facebook, MSN and Gmail are all perfect tools for the urban businessman or woman to keep track of and stay up-to-date with contacts. "But in the end, networking is about meeting and talking to people face-to-face," says mingling expert Mia Forsgren at Begriplig.

A crash course in IP strategy

"Publish, publish, publish!" Sound familiar? So to meet the researcher's wishes, do you scribble a patent application with lipstick on a napkin and send it in? At the seminar Patent Strategies in the Biotech Company, you will have the chance to find out why this might not be the best idea.

Hey Klementina Österberg ...

... CEO at GU Holding, which awards SEK 120, 000 to three female entrepreneurs.

Enjoy Stockholm - the capital of Scandinavia

Welcome to Stockholm! Built on 14 islands, you are never far from the water in the capital of Sweden. Stockholm offers a wide range of museums, theaters, and attractions. Whatever your interest might be: history, art, music or design, you can find it here!

Diagnostics for personalized medicine

Per Matsson from Phadia anticipates changes in the standards for health care. Accordiing to him, expensive new drugs will create a market for more extensive diagnostics.

BMAs: Run your own business

After graduation you must decide: be an employee or start your own business. This is not really the situation for BMAs today, but a collaborative project between Swedish public actors and some companies aims to change that and make entrepreneurs of BMAs.

Datorn förutsäger hur vi reagerar på läkemedel

En nyutkommen avhandling från Uppsala universitet beskriver hur datorbaserade in silico-metoder kan användas för att förutsäga interaktioner mellan läkemedelsmolekyler och farmakologiskt viktiga transportproteiner.

Två steg framåt för Bioinvent

Bioinvent och partnern Trombogneics har avslutat fas I studien av cancersubstansen TB-403. Resultaten visar att substansen tolereras väl och endast ger ett fåtal biverkningar. Nyligen slöt också det svenska bolaget ett licensavtal med japanska Daiichi.

Cate Poulsen, Qiagen

Why are you going to Scanlab and Biotech Forum?

Reidar Rasmussen, Labmodul

Why are you going to Scanlab and Biotech Forum?

Diagnostics to deal with new diseases

Maria Brytting at the Swedish Institute for Infectious Disease Control, SMI, will share her experiences from April 2009 when the new influenza A virus, H1N1, was first reported globally.